Lanreotide Autogel 120mg dose intervals (28, 42, 56 days) evaluated for acromegaly efficacy and safety
Effect of 120mg Somatuline Autogel at Different Dose Intervals (28, 42 or 56 Days) in Patients With Acromegaly
Abstract
Lanreotide Autogel 120mg at 28, 42, or 56-day intervals was evaluated for efficacy and safety in acromegaly patients, compared to previous octreotide LAR.